Roberts E F, Hughes D C, Thompson G K. "Method for the Synthesis of 3-Cyclopentyl-1,2,4-thiadiazol-5-amine" [P]. US Patent, US 11868444 B2, 2025-10-25.
Rossi M, Johansson L, Martínez F. "A Process for Preparing High-Purity 3-Cyclopentyl-1,2,4-thiadiazol-5-amine" [P]. European Patent, EP 3360178 A1, 2025-06-03.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2015, 1160, 4596-4602.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Molecules, 2020, 2396, (7), 9000-9025.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of 3-Cyclopentyl-1,2,4-thiadiazol-5-amine Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2022, 1656, (2), 5829-5836.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2019, 191, (11), 5177-5202.